The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.
SAN FRANCISCO, CA—A novel percutaneous ventricular assist device (pVAD) appears to offer comparable safety to an…

SAN FRANCISCO, CA—A novel percutaneous ventricular assist device (pVAD) appears to offer comparable safety to an…

Following a period of reduced pertussis activity during 2020–2021, South Africa experienced a marked resurgence in 2022 and 2023. Case numbers declined through 2024 but have shown a gradual increase during 2025.
From January to October 2025, a…
This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!

A week after The BMJ published a highly publicized paper claiming stem cell therapy can reduce the risk of heart failure, sleuths have unearthed what they are calling “serious” inconsistencies in the data.
The paper claims the…

Dr. Neil Cornwell, a family medicine physician in Boston completing his residency, has struggled with anxiety “for quite some time,” but was never able to put a label on it, he tells TODAY.com. So when he and his fiancée adopted a dog with…
This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!

A new report from the World Health Organization (WHO) is calling for bold steps to ensure equitable access to future tuberculosis (TB) vaccines.
Although there is one currently licensed vaccine for TB, its age—it was first…

A large-scale, real-world evidence study by Theranica found that early acute treatment with remote electrical neuromodulation (REN), or Nerivio, significantly reduced migraine outcomes. The study, titled The Effect of Treatment Onset Time on…